Meeting
2013 ASCO Annual Meeting
Use of tumor exome analysis to reveal neo-antigen-specific T-cell reactivity in ipilimumab-responsive melanoma.
Authors
Nienke van Rooij
The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands
Nienke van Rooij , John B. A. G. Haanen , Marit van Buren , Daisy Philips , Mireille Toebes , Bianca Heemskerk , Laura van Dijk , Sam Behjati , Michael R. Stratton , Ron M Kerkhoven , Can Kesmir , Pia Kvistborg , Ton Schumacher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Melanoma/Skin Cancers
Citation
J Clin Oncol 31, 2013 (suppl; abstr 9085)
DOI
10.1200/jco.2013.31.15_suppl.9085
Abstract #
9085
Poster Bd #
50D
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Genomic and immune landscape of metastatic melanoma (MM) treated with pembrolizumab (PEM).
First Author: Yada Kanjanapan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
First Author: Takafumi Okayama
Poster
2023 ASCO Annual Meeting
T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.
First Author: Stefan Barisic
Poster
2023 ASCO Annual Meeting
EO2401 (E) peptide immunotherapy + nivolumab (N) +/- bevacizumab (B) in recurrent glioblastoma (GB): EOGBM1-18/ROSALIE.
First Author: Wolfgang Wick